pentobarbital will minimize the level or outcome of mifepristone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. CYP3A4 inducers have not been analyzed, coadministration not advised by company
pentobarbital will decrease the extent or impact of armodafinil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Mysterious.
pentobarbital will lessen the level or effect of fentanyl transdermal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Coadministration of fentanyl with CYP3A4 inducers could lead on into a decrease in fentanyl plasma concentrations, deficiency of efficacy or, potentially, advancement of the withdrawal syndrome in the affected person who has created Bodily dependence to fentanyl.
pentobarbital decreases effects of hemin by pharmacodynamic antagonism. Use Caution/Observe. Medicines that raise delta-aminolevulinic acid synthetase may lower hemin outcome.
pentobarbital will decrease the level or outcome of alfentanil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.
pentobarbital will reduce the extent or impact of clarithromycin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.
pentobarbital will minimize the extent or effect of eletriptan by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
pentobarbital will reduce the extent or influence of aripiprazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep how to get pentobarbital track of.
pentobarbital will minimize the level or influence of eltrombopag by affecting hepatic enzyme CYP2C9/10 metabolism. Use Warning/Keep track of.
Exercising warning when a barbiturate is administered into a nursing girl; compact quantities of barbiturates are excreted during the milk
pentobarbital will lower the extent or result of ramelteon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unknown.
pentobarbital will lessen the level or result of norgestrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Closely. Reasonable CYP3A4 inducers may lessen progestin focus; think about utilization of additional barrier solutions
Barbiturates can induce hepatic microsomal enzymes leading to amplified metabolism and lessened anticoagulant response of oral anticoagulants (eg, warfarin, acenocoumarol, dicumarol, and phenprocoumon); clients stabilized on anticoagulant therapy may perhaps need dosage adjustments if barbiturates are additional to or withdrawn from their dosage routine
pentobarbital will minimize the extent or influence of vinblastine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unknown.